N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide

C114H127N35O7 — CID 158247359

IUPACN-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide
SMILESCOc1ccc(CNC(=O)C[C@H]2CCCN2c2ccnc(-n3ccnc3)n2)cc1OC.Cc1cn(C)c2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cc1cn(C)c2ccc(CNC(=O)[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cn1ccc2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc21.Cn1cnc2cc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)ccc21
InChIInChI=1S/C24H27N7O.2C23H25N7O.C22H24N8O.C22H26N6O3/c1-17-15-29(2)21-6-5-18(12-20(17)21)14-27-23(32)13-19-4-3-10-31(19)22-7-8-26-24(28-22)30-11-9-25-16-30;1-16-14-28(2)19-6-5-17(12-18(16)19)13-26-22(31)20-4-3-10-30(20)21-7-8-25-23(27-21)29-11-9-24-15-29;1-28-11-7-18-5-4-17(13-20(18)28)15-26-22(31)14-19-3-2-10-30(19)21-6-8-25-23(27-21)29-12-9-24-16-29;1-28-15-26-18-11-16(4-5-19(18)28)13-25-21(31)12-17-3-2-9-30(17)20-6-7-24-22(27-20)29-10-8-23-14-29;1-30-18-6-5-16(12-19(18)31-2)14-25-21(29)13-17-4-3-10-28(17)20-7-8-24-22(26-20)27-11-9-23-15-27/h5-9,11-12,15-16,19H,3-4,10,13-14H2,1-2H3,(H,27,32);5-9,11-12,14-15,20H,3-4,10,13H2,1-2H3,(H,26,31);4-9,11-13,16,19H,2-3,10,14-15H2,1H3,(H,26,31);4-8,10-11,14-15,17H,2-3,9,12-13H2,1H3,(H,25,31);5-9,11-12,15,17H,3-4,10,13-14H2,1-2H3,(H,25,29)/t19-;20-;19-;2*17-/m11111/s1
InChIKeyGGHBLTBXAUUDEZ-CYJYBXFDSA-N
MW2099.51 g/mol
LogP13.29
Rot. Bonds31

About N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide

N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide (PubChem CID 158247359) has the molecular formula C114H127N35O7 and a molecular weight of 2099.51 g/mol. Its IUPAC name is N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide.

Molecular Properties

Compound NameN-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide
PubChem CID158247359
Molecular FormulaC114H127N35O7
Molecular Weight2099.51 g/mol
Exact Mass2098.07
IUPAC NameN-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide
SMILESCOc1ccc(CNC(=O)C[C@H]2CCCN2c2ccnc(-n3ccnc3)n2)cc1OC.Cc1cn(C)c2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cc1cn(C)c2ccc(CNC(=O)[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cn1ccc2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc21.Cn1cnc2cc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)ccc21
InChIInChI=1S/C24H27N7O.2C23H25N7O.C22H24N8O.C22H26N6O3/c1-17-15-29(2)21-6-5-18(12-20(17)21)14-27-23(32)13-19-4-3-10-31(19)22-7-8-26-24(28-22)30-11-9-25-16-30;1-16-14-28(2)19-6-5-17(12-18(16)19)13-26-22(31)20-4-3-10-30(20)21-7-8-25-23(27-21)29-11-9-24-15-29;1-28-11-7-18-5-4-17(13-20(18)28)15-26-22(31)14-19-3-2-10-30(19)21-6-8-25-23(27-21)29-12-9-24-16-29;1-28-15-26-18-11-16(4-5-19(18)28)13-25-21(31)12-17-3-2-9-30(17)20-6-7-24-22(27-20)29-10-8-23-14-29;1-30-18-6-5-16(12-19(18)31-2)14-25-21(29)13-17-4-3-10-28(17)20-7-8-24-22(26-20)27-11-9-23-15-27/h5-9,11-12,15-16,19H,3-4,10,13-14H2,1-2H3,(H,27,32);5-9,11-12,14-15,20H,3-4,10,13H2,1-2H3,(H,26,31);4-9,11-13,16,19H,2-3,10,14-15H2,1H3,(H,26,31);4-8,10-11,14-15,17H,2-3,9,12-13H2,1H3,(H,25,31);5-9,11-12,15,17H,3-4,10,13-14H2,1-2H3,(H,25,29)/t19-;20-;19-;2*17-/m11111/s1
InChIKeyGGHBLTBXAUUDEZ-CYJYBXFDSA-N
XLogP13.29
TPSA430.77 Ų
H-Bond Donors5
H-Bond Acceptors37
Rotatable Bonds31
Heavy Atoms156
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002099.51
LogP ≤ 513.29
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1037

Analyze N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide?
The IUPAC name of N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide (CID 158247359) is N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide.
What is the SMILES notation for N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide?
The canonical SMILES for N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide is COc1ccc(CNC(=O)C[C@H]2CCCN2c2ccnc(-n3ccnc3)n2)cc1OC.Cc1cn(C)c2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cc1cn(C)c2ccc(CNC(=O)[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc12.Cn1ccc2ccc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)cc21.Cn1cnc2cc(CNC(=O)C[C@H]3CCCN3c3ccnc(-n4ccnc4)n3)ccc21.
What is the InChIKey of N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide?
The InChIKey is GGHBLTBXAUUDEZ-CYJYBXFDSA-N. The full InChI is InChI=1S/C24H27N7O.2C23H25N7O.C22H24N8O.C22H26N6O3/c1-17-15-29(2)21-6-5-18(12-20(17)21)14-27-23(32)13-19-4-3-10-31(19)22-7-8-26-24(28-22)30-11-9-25-16-30;1-16-14-28(2)19-6-5-17(12-18(16)19)13-26-22(31)20-4-3-10-30(20)21-7-8-25-23(27-21)29-11-9-24-15-29;1-28-11-7-18-5-4-17(13-20(18)28)15-26-22(31)14-19-3-2-10-30(19)21-6-8-25-23(27-21)29-12-9-24-16-29;1-28-15-26-18-11-16(4-5-19(18)28)13-25-21(31)12-17-3-2-9-30(17)20-6-7-24-22(27-20)29-10-8-23-14-29;1-30-18-6-5-16(12-19(18)31-2)14-25-21(29)13-17-4-3-10-28(17)20-7-8-24-22(26-20)27-11-9-23-15-27/h5-9,11-12,15-16,19H,3-4,10,13-14H2,1-2H3,(H,27,32);5-9,11-12,14-15,20H,3-4,10,13H2,1-2H3,(H,26,31);4-9,11-13,16,19H,2-3,10,14-15H2,1H3,(H,26,31);4-8,10-11,14-15,17H,2-3,9,12-13H2,1H3,(H,25,31);5-9,11-12,15,17H,3-4,10,13-14H2,1-2H3,(H,25,29)/t19-;20-;19-;2*17-/m11111/s1.
What are the key properties of N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide?
N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide has a molecular weight of 2099.51 g/mol, XLogP of 13.29, 31 rotatable bonds, 5 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3,4-dimethoxyphenyl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;(2R)-N-[(1,3-dimethylindol-5-yl)methyl]-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidine-2-carboxamide;N-[(1,3-dimethylindol-5-yl)methyl]-2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylbenzimidazol-5-yl)methyl]acetamide;2-[(2R)-1-(2-imidazol-1-ylpyrimidin-4-yl)pyrrolidin-2-yl]-N-[(1-methylindol-6-yl)methyl]acetamide is sourced from PubChem (CID 158247359), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).